SCHEMBL4149043

SCHEMBL4149043

NC(c1nc2cc(Cl)ccc2[nH]1)c1ccccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 5/20 0.38
RAB9A P51151 4/20 0.38
LMNA P02545 3/20 0.38
MEN1 O00255 3/20 0.38
MAPT P10636 3/20 0.38
KMT2A Q03164 3/20 0.38
NPC1 O15118 3/20 0.38
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALPL P05186 1/20 0.38
GLA P06280 1/20 0.38
ALPG P10696 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4826538 0.84 GAA (0.46) GAACYP3A4CYP1A2KDM4EALDH1A1
SCHEMBL586819 0.84 GAA (0.46) GAACYP3A4CYP1A2KDM4EALDH1A1
SCHEMBL5097077 0.81 ROCK2 (0.49) GAACYP1A2KDM4EALDH1A1RAB9A
SCHEMBL4150274 0.80 ROCK2 (0.52) GAACYP3A4CYP1A2KDM4ERAB9A
SCHEMBL1479636 0.77 LMNA (0.42) GAACYP1A2KDM4EALDH1A1LMNA
SCHEMBL580393 0.77 LMNA (0.42) GAACYP1A2KDM4EALDH1A1LMNA
SCHEMBL5104456 0.77 LMNA (0.42) GAACYP1A2KDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL586606 0.76 LMNA (0.41) GAACYP1A2KDM4EALDH1A1RAB9A
Hydrochloric Acid SCHEMBL29915499 0.76 LMNA (0.41) GAACYP1A2KDM4EALDH1A1RAB9A
Hydrochloric Acid SCHEMBL587093 0.76 LMNA (0.41) GAACYP1A2KDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-07-16 US disclosed
US-7429597-B2 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-09-30 US disclosed
US-20080132496-A1 CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2008-06-05 US disclosed
US-7326791-B2 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) 2008-02-05 US disclosed
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132496-A1 CARBOXYLIC ACID AMIDES, THE PREPARATION THEREOF, AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS F12, F11, F2 GAA 370/4885CYP3A4 95/4885CYP1A2 48/4885
US-20040176603-A1 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions F11, F12, F2 GAA 2024/4885CYP3A4 114/4885CYP1A2 98/4885
US-20090181958-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROBICYCLES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS F12, F11, F2 GAA 2665/4885CYP3A4 80/4885CYP1A2 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.